SUZHOU, China – Navigating the obstacle course of China's regulatory system requires strategic thinking, long-term planning, creative problem solving and it doesn't hurt to have deep pockets, according to the experts discussing cross-border approvals at the Chinabio Partnering conference.
SUZHOU, China – On the eve of a key biopharmaceutical partnering fest – the Chinabio Partnering Forum begins here today – BioWorld Today took a closer look at what it takes for successful dealmaking in the most populous nation on earth. The experts all agree: the landscape for licensing in China is getting more crowded with competitors.
SUZHOU, China – On the eve of a key biopharmaceutical partnering fest – the Chinabio Partnering Forum begins here today – BioWorld Asia took a closer look at what it takes for successful dealmaking in the most populous nation on earth. The experts all agree: the landscape for licensing in China is getting more crowded with competitors.
SUZHOU, China – With the 6th Chinabio Partnering Forum happening this week – designed to foster cross-border partnering – the event is considered the best place for the world to meet up-and-coming Chinese life science companies. Several trends driving partnering this year promise to make the event the liveliest yet.
SUZHOU, China – With the 4th Chinabio Partnering Forum happening this week – designed to foster cross-border partnering – the event is considered the best place for the world to meet up-and-coming Chinese life science companies. Several trends driving partnering this year promise to make the event the liveliest yet.
SHANGHAI – Authorities in Beijing are loosening price controls for a select number of commonly used, low-cost medicines. While few innovative drugs are expected to be affected, the move signals the government is willing to take a step back when necessary in its ongoing efforts to rein in drug costs.
SHANGHAI – Alk-Abello A/S has signed a deal in which up and comer specialty pharmaceutical, Eddingpharm Co. Ltd., will handle the sales and distribution of Alk's allergy immunotherapy treatment here, products it hs been selling under its own steam since 2005.
SHANGHAI – Authorities in Beijing are loosening price controls for a select number of commonly used, low-cost medicines. While few innovative drugs are expected to be affected, the move signals the government is willing to take a step back when necessary in its ongoing efforts to rein in drug costs.
SHANGHAI – At the 4th Annual Biopharma China Congress in Shanghai last week, smaller biotechs and established contract research organizations (CRO) rubbed shoulders with government-funded academics. Meanwhile the China division of Sanofi SA of France was one of the only international companies in attendance.
SHANGHAI – Betta Pharmaceuticals Co. Ltd. (Betta Pharma), with the first small molecule anticancer drug in China, is aiming to go public in China later this year.
